503 related articles for article (PubMed ID: 19486763)
21. Research funding. Politics and funding in the U.S. public biomedical R&D system.
Hegde D; Mowery DC
Science; 2008 Dec; 322(5909):1797-8. PubMed ID: 19095928
[No Abstract] [Full Text] [Related]
22. Changes in NIH review procedures: strengths and weaknesses.
Adler KB; Abraham E
Am J Respir Cell Mol Biol; 2009 Aug; 41(2):127-8. PubMed ID: 19620406
[No Abstract] [Full Text] [Related]
23. Senators urge scrutiny of research on humans. Bipartisan proposal to call for revisions in federal oversight of widening field of biomedical testing.
Lovern E
Mod Healthc; 2002 Apr; 32(17):8-9. PubMed ID: 12024774
[No Abstract] [Full Text] [Related]
24. The healthcare bubble through the lens of pain research, practice, and policy: advice for the new President and Congress.
Green CR
J Pain; 2008 Dec; 9(12):1071-3. PubMed ID: 19038768
[No Abstract] [Full Text] [Related]
25. The stimulus package and medical therapeutics.
Somberg JC
Am J Ther; 2009; 16(2):105. PubMed ID: 19262356
[No Abstract] [Full Text] [Related]
26. Prevent Alzheimer's disease by 2020: a national strategic goal.
Khachaturian ZS; Khachaturian AS
Alzheimers Dement; 2009 Mar; 5(2):81-4. PubMed ID: 19328433
[No Abstract] [Full Text] [Related]
27. More gold and more fleece: improving the legal sanctions against medical research fraud.
O'Reilly JT
Adm Law Rev; 1990; 42(3):393-422. PubMed ID: 15991411
[No Abstract] [Full Text] [Related]
28. Biomedical research. Stimulus funding elicits a tidal wave of 'challenge grants'.
Kaiser J
Science; 2009 May; 324(5929):867. PubMed ID: 19443754
[No Abstract] [Full Text] [Related]
29. Biomedical research. A cure for medicine's ailments?
Kaiser J
Science; 2006 Mar; 311(5769):1852-4. PubMed ID: 16574835
[No Abstract] [Full Text] [Related]
30. Designing a data and safety monitoring plan.
Slimmer L; Andersen B
West J Nurs Res; 2004 Nov; 26(7):797-803. PubMed ID: 15466615
[TBL] [Abstract][Full Text] [Related]
31. One year in--Obama's biotech scorecard.
Fox JL
Nat Biotechnol; 2010 Mar; 28(3):193-6. PubMed ID: 20212475
[No Abstract] [Full Text] [Related]
32. Responding to stimuli.
Mahapatra A
ACS Chem Biol; 2009 Apr; 4(4):233. PubMed ID: 19371128
[No Abstract] [Full Text] [Related]
33. Does exclusion or inclusion better protect women?
Shultz MM
J Gend Specif Med; 1998; 1(2):18-22. PubMed ID: 11281007
[No Abstract] [Full Text] [Related]
34. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
35. NIH roadmap: course change for the big ship.
Pentecost MJ
J Am Coll Radiol; 2004 Apr; 1(4):239-40. PubMed ID: 17411571
[No Abstract] [Full Text] [Related]
36. Peer review at National Institutes of Health: small steps forward.
Johnston SC; Hauser SL
Ann Neurol; 2008 Nov; 64(5):A15-7. PubMed ID: 19067350
[No Abstract] [Full Text] [Related]
37. Correcting social ills through mandatory research participation.
Ho A
Am J Bioeth; 2008 Oct; 8(10):39-40. PubMed ID: 19003706
[No Abstract] [Full Text] [Related]
38. What are the problems with the NIH guidelines? What are the solutions?
Weinberger M
Pediatr Pulmonol; 2001; Suppl 23():13-5. PubMed ID: 11886115
[No Abstract] [Full Text] [Related]
39. Comparative effectiveness casts first shadows across US industry.
Waltz E
Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
[No Abstract] [Full Text] [Related]
40. A new era in surgical research: getting back to the patient.
Kent KC; Gelijns AC
Surgery; 2009 Jun; 145(6):579-81. PubMed ID: 19486754
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
